Full-Time

Business Advisor

Confirmed live in the last 24 hours

Viatris

Viatris

10,001+ employees

Global healthcare company providing medicines access

No salary listed

Junior, Mid

Tasmania, Australia + 1 more

More locations: Victoria, Australia

Candidates must be eligible to work in Australia (Australian Citizen or appropriate Visa holder).

Category
Field Sales
Sales & Account Management
Required Skills
Sales
Data Analysis
Requirements
  • Bachelor’s degree or equivalent in Pharmacy, Science or Sales
  • At least 1 years experience working within Australia’s generic market
  • 1-2 years’ experience in B2B complex sales environments
  • Proven track record of success in exceeding sales targets
  • Excellent communication skills (written and verbal)
  • Must be eligible to work in Australia (Australian Citizen or appropriate Visa holder)
Responsibilities
  • Maintain the designated territory ensuring continuation of optimum service to 1st line accounts
  • Exceeding net sales target of dispensary and OTC pharmacy products within a defined territory of supporting customers and acquisition targets
  • Maintain loyalty of 1st line accounts through building close relationships to ensure their requirements are being met by the company’s products where possible
  • Execute agreed business tactics to optimize substitution opportunities
  • Design & execute quarterly business plans which include targets, action plan & outcomes for each account
  • Facilitate a 1st class sales experience using business insights, analytics & innovative deal-level strategies
  • Acknowledge & overcome customer concerns. Take ownership of territory issues & provide appropriate solutions. Escalate to Regional Business Manager if required
  • Consistently record & assess call outcomes in call notes within the required system.

Viatris is a global healthcare company that provides a wide range of medicines, combining generic and brand-name products to meet healthcare needs around the world. Their products work by ensuring access to high-quality medications for various health conditions, from acute illnesses to chronic diseases, reaching approximately 1 billion patients in 2022 alone. What sets Viatris apart from its competitors is its extensive and diverse portfolio of medicines, along with a unique global supply chain that allows them to deliver medications efficiently to those in need. The company's goal is to empower people to live healthier lives at every stage, ensuring that healthcare is accessible to everyone.

Company Size

10,001+

Company Stage

IPO

Headquarters

Canonsburg, Pennsylvania

Founded

1961

Simplify Jobs

Simplify's Take

What believers are saying

  • Viatris can leverage digital health trends to expand telemedicine and remote monitoring services.
  • The rise of value-based healthcare aligns with Viatris' focus on patient outcomes and cost-effectiveness.
  • Expansion in emerging markets offers Viatris opportunities to increase market presence and reach.

What critics are saying

  • Increased competition from low-cost generics could erode Viatris' market share.
  • Patent expirations in 2025 may lead to revenue loss from generic competition.
  • Ongoing opioid litigation could result in financial liabilities and reputational damage.

What makes Viatris unique

  • Viatris bridges the gap between generics and brands, offering a unique healthcare approach.
  • The company has a diverse portfolio, supplying medicines to 1 billion patients annually.
  • Viatris' global supply chain is designed to reach patients worldwide efficiently.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Life Insurance

401(k) Retirement Plan

401(k) Company Match

Wellness Program

Paid Holidays

Company News

PharmiWeb
May 7th, 2025
Viatris Announces Quarterly Dividend

PITTSBURGH, May 7, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that on May 5, 2025, its Board of Directors declared a quarterly dividend of $0.12 per share for each issued and outstanding share of the Company's common stock. The dividend is payable on June 16, 2025, to shareholders of record as of the close of business on May 23, 2025.About ViatrisViatris Inc. (Nasdaq: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris

PR Newswire
Mar 28th, 2025
Viatris To Report First Quarter 2025 Financial Results On May 8, 2025

PITTSBURGH, March 28, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) will report first quarter 2025 financial results on Thursday, May 8, 2025. Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.Investors and the general public are invited to listen to a live webcast of the call at investor.viatris.com or by calling 844.308.3344 or 412.317.1896 for international callers. A replay of the webcast also will be available on the website.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally

PR Newswire
Mar 5th, 2025
Viatris To Present At The Barclays 27Th Annual Global Healthcare Conference

PITTSBURGH, March 5, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS), a global healthcare company, will present at the Barclays 27th Annual Global Healthcare Conference in Miami Beach, FL on Tuesday, March 11, 2025. The company's fireside chat will begin at 2 p.m. ET.A live webcast of the event at can be found at investor.viatris.com. An archived version of the presentation will be available following the live event and can be accessed at the same location for a limited time.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally

PR Newswire
Feb 27th, 2025
Viatris Maintains Dividend Policy For 2025 And Announces Quarterly Dividend

PITTSBURGH, Feb. 27, 2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that on February 24, 2025, its Board of Directors approved a 2025 dividend policy of 48 cents ($0.48) per share and declared a quarterly dividend of 12 cents ($0.12) for each issued and outstanding share of the Company's common stock. The dividend is payable on March 18, 2025, to shareholders of record at the close of business on March 10, 2025. This marks the fifth consecutive year the Company has paid a dividend.About ViatrisViatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally